Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Lipoic acid group:Routine Therapy and administration of Lipoic acid injection
Blank control group:Routine Therapy and administration of placebo
Sponsors
Maoming People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: (1) Patients aged from 18 to 75 years old; (2) Mild patients with confirmed COVID-19 according to the diagnostic criteria of "novel coronavirus Infection Diagnosis and Treatment Plan (Trial 6th Edition)" issued by the National Health and Safety Commission; (3) Patients and their families voluntarily participated in the study and signed an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Female patients during pregnancy or lactation; (2) Patients allergic to lipoic acid or similar drugs (B vitamins), previously intolerant to the recommended dose of lipoic acid; (3) Patients who are taking part in clinical trials of other drugs; (4) Patients are taking other foods or drugs with antioxidant effect, such as vitamin C, vitamin E, etc. (5) Patients with other serious diseases that may threaten life, such as cancer.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression rate from mild to critical/severe; | — |
Secondary
| Measure | Time frame |
|---|---|
| NEW Score;Hospital Stay;30-day all-cause mortality;Levels of Inflammatory Factors and Oxidative Stress Markersive Stress Markers; | — |
Countries
China
Contacts
Public ContactChen Chunbo
Maoming People's Hospital
Outcome results
None listed